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Abstract
Background
Surgical resection with microscopically negative margins remains the main curative option
for pancreatic cancer; however, in practice intraoperative delineation of resection margins is
challenging. Ambient mass spectrometry imaging has emerged as a powerful technique for
chemical imaging and real-time diagnosis of tissue samples. We applied an approach com-
bining desorption electrospray ionization mass spectrometry imaging (DESI-MSI) with the
least absolute shrinkage and selection operator (Lasso) statistical method to diagnose pan-
creatic tissue sections and prospectively evaluate surgical resection margins from pancre-
atic cancer surgery.
Methods and Findings
Our methodology was developed and tested using 63 banked pancreatic cancer samples
and 65 samples (tumor and specimen margins) collected prospectively during 32 pancrea-
tectomies from February 27, 2013, to January 16, 2015. In total, mass spectra for 254,235
individual pixels were evaluated. When cross-validation was employed in the training set of
samples, 98.1% agreement with histopathology was obtained. Using an independent set
of samples, 98.6% agreement was achieved. We used a statistical approach to evaluate
177,727 mass spectra from samples with complex, mixed histology, achieving an agree-
ment of 81%. The developed method showed agreement with frozen section evaluation of
specimen margins in 24 of 32 surgical cases prospectively evaluated. In the remaining eight
patients, margins were found to be positive by DESI-MSI/Lasso, but negative by frozen sec-
tion analysis. The median overall survival after resection was only 10 mo for these eight
patients as opposed to 26 mo for patients with negative margins by both techniques. This
observation suggests that our method (as opposed to the standard method to date) was
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able to detect tumor involvement at the margin in patients who developed early recurrence.
Nonetheless, a larger cohort of samples is needed to validate the findings described in this
study. Careful evaluation of the long-term benefits to patients of the use of DESI-MSI for sur-
gical margin evaluation is also needed to determine its value in clinical practice.
Conclusions
Our findings provide evidence that the molecular information obtained by DESI-MSI/Lasso
from pancreatic tissue samples has the potential to transform the evaluation of surgical
specimens. With further development, we believe the described methodology could be rou-
tinely used for intraoperative surgical margin assessment of pancreatic cancer.
Author Summary
WhyWas This Study Done?
• Ambient ionization mass spectrometry imaging can provide accurate diagnostic informa-
tion differentiating cancerous from noncancerous tissue samples and has been recently
shown to be particularly powerful in helping pathologists and surgeons determine whether
cancer reaches the edge (margin) of the resection specimen in real time during surgery.
• This study was performed to evaluate the feasibility and efficacy of this method during
surgery for pancreatic cancer, one of the most lethal human cancers.
What Did the Researchers Do and Find?
• Our methodology was developed and tested using 63 banked pancreatic cancer samples
and 65 samples (tumor and specimen margins) collected prospectively during 32 pan-
createctomies performed from 2013 to 2015.
• We found that desorption electrospray ionization mass spectrometry imaging (DESI-
MSI) allows discrimination of normal pancreatic and pancreatic cancer tissue based on
diagnostic metabolic signatures and has the potential to assist in surgical decision mak-
ing by informing the surgeon whether the entire tumor has been removed or not.
What Do These Findings Mean?
• These findings provide novel information on molecular markers of pancreatic cancer
and showcase the value of this methodology as an adjunct to the current pathologic
method (frozen section analysis) for determining the completeness of cancer surgery.
• The data reported in this study could be made available during actual surgery, and allow
the surgeon to extend the boundaries of surgery to remove any residual tumor discov-
ered by DESI-MSI at the margin.
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Introduction
Resection of pancreatic cancer is a complex and technically demanding surgical procedure due
to the location of the pancreas adjacent to many critical organs and vascular structures, and the
locally infiltrative nature of pancreatic adenocarcinoma. Surgical resection of pancreatic cancer
remains the main curative option for this disease. It is well accepted that complete resection
with negative surgical margins is associated with improved long-term survival [1–4]. This find-
ing calls for careful evaluation of surgical resection margins intraoperatively. Positive margins,
defined as the presence of tumor cells at the specimen edge and/or the resection bed, have been
associated with increased local recurrence and decreased overall survival [1]. During surgical
resection, depending on the location of the tumor (in the head or body/tail of the gland), up to
five surgical margins are typically evaluated by an expert team of pathologists using histologic
analysis of frozen sections. These margins include the pancreatic neck margin, the retroperito-
neal/uncinate process margin, the vascular groove margin, the gastric/proximal duodenal mar-
gin, and the bile duct margin. However, in practice, the accuracy of intraoperative delineation
of pancreatectomy margins can be variable and subjective, with false-negative results occurring
in up to 20%–30% of pancreatic adenocarcinoma patients [5–7]. Consequently, the need exists
for developing more accurate, more time-efficient, and less operator-dependent technologies
to evaluate specimen margins during pancreatic cancer surgery [8]. We have recently described
an approach combining desorption electrospray ionization mass spectrometry imaging
(DESI-MSI) with the least absolute shrinkage and selection operator (Lasso) statistical method
to classify tissue sections and evaluate surgical resection margins during gastric cancer surgery
[9]. We describe herein the application of this methodology to the intraoperative evaluation of
pancreatic cancer surgical margins.
In the last few years, ambient ionization mass spectrometry (MS) has become a powerful
approach for tissue imaging and diagnosis [10–13]. In particular, DESI-MSI is the most exten-
sively used ambient ionization MS technique for chemical imaging and diagnosis of tissue sam-
ples [13]. In DESI-MSI, a spray of charged droplets is directed toward a tissue sample, allowing
chemicals to be dissolved at the sample surface, ionized by mechanisms similar to electrospray
ionization, and transferred into a mass spectrometer, where the mass-to-charge ratios (m/z) of
molecular ions and their abundances are measured [14]. By rastering the tissue sample under-
neath the DESI-MSI spray spot and collecting a mass spectrum at every point, it is possible to
determine the distribution of numerous molecular species with a typical spatial resolution of
200 μm at an acquisition rate of 0.5 s/pixel. Besides DESI-MSI, other ambient ionization tech-
niques including probe electrospray ionization [15], solid-probe-assisted nanoelectrospray ion-
ization [16], touch spray [17], and rapid evaporative ionization MS [18] have been used for
cancer tissue diagnosis and surgical margin evaluation [13]. Various human cancer tissues
have been investigated by ambient ionization MS, including liver [19], breast [20,21], brain
[22], kidney [23], prostate [24,25], bladder [26], gastric [25], colorectal [25], and ovarian [26]
cancers. In this study, we tested the usefulness of DESI-MSI to classify pancreatic tissue as
cancerous or benign and to evaluate surgical margins collected from pancreatic cancer surgery.
Methods
Ethics Statement
Banked tissue samples were obtained without identifiable or clinical information. Therefore,
the Stanford institutional review board (IRB) determined that this portion of the research did
not include human subject research and was exempt from full review. However, Stanford’s IRB
ethical review committee determined that the portion of the study involving patients was
Pancreatic Cancer Diagnosis by Mass Spectrometry Imaging
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human subject research, and thus IRB approval was obtained. Approval was also obtained
from Stanford’s Cancer Institute Scientific Review Committee. Written informed consent was
obtained for all patients recruited.
Banked Human Malignant and Benign Pancreatic Tissues
Sixty-three frozen human tissue specimens including pancreatic ductal carcinoma and benign
pancreatic tissue were obtained from the Stanford Tissue Procurement Facility under approved
IRB protocol. Samples were stored in a −80°C freezer until sectioned (15 μm thick) using a
Leica CM1950 cryostat (Leica Microsystems). No sample size determination was done for this
study. After sectioning, the glass slides were stored in a −80°C freezer. Prior to mass spectrome-
try imaging, the glass slides were dried in a desiccator for approximately 15 min.
Prospective Collection of Surgical Samples
Thirty-two pancreatic cancer patients scheduled to undergo pancreatectomy at Stanford Uni-
versity Hospital were preoperatively consented for our study. All patients gave written consent
under IRB approval (protocol number 25655), approved by Stanford’s IRB committee (IRB 7).
Inclusion criteria were that the patient was scheduled to undergo surgery for pancreatic cancer
removal. No exclusion criteria were applied. During surgery, the neck and/or retroperitoneal/
uncinate margins of the specimen were subjected to frozen section histopathologic evaluation,
as is routinely performed independently of our research. In parallel to the process of frozen sec-
tion, adjacent 5- and 15-μm thick tissue sections of each margin were obtained for DESI-MSI.
For all but one case, a sample of the tumor was obtained in addition to the surgical margins. In
total, 65 surgical tissue samples were evaluated by DESI-MSI during the period from February
27, 2013, to January 16, 2015.
Analyses
The MS and histologic analyses reported were chosen during monthly meetings between the
leading investigators or a subgroup of the investigators. The analysis was planned a priori and
was based on a recent successful investigation that the authors had performed in gastric cancer.
The statistical methods were optimized during the study based on the results obtained and the
need for refinement of the methods.
Mass Spectrometry Imaging
A 2-D DESI-MSI source (Prosolia) coupled to an LTQ XL mass spectrometer (Thermo Scien-
tific) was used for tissue imaging. DESI-MSI was performed in the negative ion mode fromm/z
90 tom/z 1,200. The spatial resolution of the imaging experiments was 200 μm. The histologi-
cally compatible solvent system, dimethylformamide:acetonitrile 1:1 (v/v), was used for analy-
sis at a flow rate of 0.8 μl/min. The N2 pressure was set to 175 psi. After DESI-MSI, the same
tissue section was subjected to H&E staining for histopathologic evaluation by expert patholo-
gist T. A. L. in a blind manner. For ion identification, tandemMS analyses were performed.
DESI-MSI data were collected on entire tissue sections. After DESI-MSI, the slides were
stained and evaluated by the pathologist. Regions including lymphocytes, inflammation, and
necrosis were observed in part of the samples, but were not selected within the pixels analyzed
by statistical analysis because the goal of this study was to identify and discriminate cancer
from normal pancreatic tissue, and not to characterize these other histologic features.
DESI-MSI is performed as a sequence of line scans, and, thus, regions of glass slide (no tissue
Pancreatic Cancer Diagnosis by Mass Spectrometry Imaging
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sample) are also analyzed. Pixels corresponding to the non-tissue area were imaged but not
included in the pixels selected.
Histopathologic Evaluation
The same tissue sections analyzed by DESI-MSI were subjected afterward to standard H&E
staining protocol. These sections were adjacent and serial to, but not the exact same, sections
used during surgery for surgical margin assessment. Pathologic evaluation was performed
using light microscopy. Regions of benign pancreatic glands, normal stroma, and pancreatic
cancer were delineated on the glass slides. Tissues that contained regions of mixed histology
were evaluated and given a percent composition for each cell/tissue type (benign glands, nor-
mal stroma or pancreatic cancer).
Statistical Analysis
The 2-D raw data obtained by DESI-MSI were converted to text files and imported to the R
package for statistical analysis. The images were plotted in R and manually segmented into
regions of interest as determined by histopathologic evaluation. Intensities for a total of 13,320
m/z values were recorded in each spectrum. To reduce complexity and account for small differ-
ences in registration between spectra, these MS features were averaged in nonoverlapping bins
of sixm/z values to yield a total of 2,220 features per spectrum. We randomly divided the
patients into one training set and two sets of test samples. Within the training set, we applied
the Lasso method (multiclass logistic regression with L1 penalty) using the glmnet 2.0–2 pack-
age in the CRAN R language library [27].
The Lasso is a shrinkage and selection method for supervised learning. It minimizes the
usual sum of squared errors (or negative log-likelihood) with a bound on the sum of the abso-
lute values of the coefficients. As a result, it yields a “sparse” solution containing the most
informative features for the prediction task, that is, models that involve only a subset of the
variables/predictors [28]. As such, it has an advantage over methods such as support vector
machines, which are not designed to yield sparse solutions. On the other hand, if interactions
between features are important, methods such as random forests and boosting may yield better
results. (We tried these approaches here, and they did not offer improvement over the Lasso
method.)
In this application, the Lasso method yields a model with parsimonious sets of features for
discriminating between pancreatic cancer, normal pancreatic glands, and normal pancreatic
stromal tissue. A mathematical weight for each statistically informative feature is calculated by
the Lasso depending on the importance that the mass spectral feature has in characterizing a
certain class. Features that do not contribute to a class of the linear model receive a weight of
zero and are disregarded. An ion whose peak height, or abundance, is important for character-
izing a certain class is given a positive weight, whereas ions for which low abundance or their
absence is important receive a negative weight. Because the features selected by the Lasso can
occur at a valley or a shoulder of an actual peak in the mass spectrum, identification of the
selected features was performed by characterizing the nearest mass peak to the statistically
selected feature.
Classification was done on a pixel by pixel basis into one of three classes: (1) benign glands,
(2) cancer, or (3) stroma. We employed 25-fold cross-validation (CV), leaving out one patient
at a time, to select the Lasso tuning parameter and to assess the predictive accuracy within the
training set. Then, the chosen model was applied to the first test set of 15 patients, from which
samples were of clear diagnosis. We then applied this method and an improved approach
Pancreatic Cancer Diagnosis by Mass Spectrometry Imaging
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using customized training sets [29] to an independent set of mixed samples (including banked
and surgical samples).
Note that the prediction performance is of main interest when evaluating the performance
of the statistical classifier. p-Values, which are commonly used to evaluate the statistical signifi-
cance of defined results between groups, are not the central focus in classification approaches
with a large number of features, as in our study, and thus are not applicable to our results. Sur-
vival probabilities were calculated based on the Kaplan-Meier method and compared using the
log-rank test.
Results
Molecular Imaging and Characterization of Pancreatic Tissue
A total of 128 human pancreatic tissues including banked specimens and tissue prospectively
collected from surgeries for our study were analyzed in the negative ion mode by DESI-MSI.
Fig 1 shows a flowchart of our study design. For the majority of the samples analyzed, the 2-D
ion images obtained showed high heterogeneity in the distribution of molecular ions. Most of
the heterogeneity in ion distribution was assigned by histopathologic evaluation as regions of
cancer, normal pancreatic glands, or normal stromal tissue. Many samples presented highly
mixed regions in which all of these histologic features were simultaneously observed. In a few
samples, other histologic features were observed by the study pathologist including regions
with acute inflammation, lymphocytes, and necrosis. These regions were not consistently seen
across samples and were not considered in our approach owing to the lack of a statistically sig-
nificant number of spectra.
The mass spectra obtained for regions of normal pancreatic glands, normal stroma, and
cancerous tissue presented high relative abundances of many molecular ions commonly attrib-
uted to lipid species in negative ion mode DESI-MSI mass spectra of human tissue (Fig 2). Nor-
mal pancreatic glands and cancerous regions showed high relative abundances of lowm/z ions
(m/z 200–400) attributed to free fatty acids (FAs), in comparison to higherm/z ions (m/z 700–
1,000) attributed to glycerophospholipids (GPs). In particular, benign glands presented higher
relative and total abundances of free FAs and FA dimers commonly observed in them/z 500–
600 range compared to both cancerous and stromal tissues. In normal pancreatic glands, the
Fig 1. Flowchart summarizing the study performed.
doi:10.1371/journal.pmed.1002108.g001
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most abundant free FAs observed were identified as oleic acid (m/z 281.2), palmitic acid (m/z
255.3), and arachidonic acid (m/z 303.3). Dimers of these species were observed atm/z 537.0
(oleic and palmitic) andm/z 563.0 (oleic and oleic), among others. In the higherm/z range,
GPs of various classes were observed including glycerophosphoinositol (PI) 38:4 atm/z 885.6,
PI(36:2) atm/z 861.5, PI(34:2) atm/z 833.5, glycerophosphoglycerol (PG) 36:3 atm/z 771.5,
and glycerophosphoetanolamine 37:5 atm/z 750.5. Cancerous tissue presented high relative
abundances of polyunsaturated FAs including arachidonic acid (m/z 303.3) and adrenic
(16-docosatetraenoic) acid (m/z 331.2). In the higherm/z range, chloride adducts of
Fig 2. Representative negative ion mode DESI-MSI mass spectra obtained from pancreatic tissue. (A) Normal pancreatic glandular tissue from
sample PC775 (note 10× zoom applied fromm/z 700 tom/z 900 to assist visualization); (B) pancreatic cancer tissue from sample PC13702; and (C)
normal pancreatic stromal tissue from sample PC0423.
doi:10.1371/journal.pmed.1002108.g002
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glycerophosphocholines (PCs) including PC(34:1) atm/z 794.4 and PC(34:0) atm/z 792.4,
and other deprotonated GPs such as PG(36:2) atm/z 773.6 and PI(38:4) atm/z 885.6, were
observed. Stromal tissue presented a characteristic lipid profile with an overall lower total lipid
abundance (total mass spectrum ion counts) compared to normal pancreatic glands and
cancerous tissue, and showed high relative intensities of oleic acid, palmitic acid, glyceropho-
sphoserine (PS) 36:1 atm/z 788.8, PS(38:1) atm/z 816.5, and PI(38:4) atm/z 885.6. Fig 3 shows
selected 2-D DESI-MSI ion images of the identified ions for the samples PC7817, which is com-
posed of 90% normal pancreatic glands and 10% normal stromal tissue, PC13702, which is
composed of 90% pancreatic cancer and 10% normal stromal tissue, and PC0423, which is
composed of purely normal stroma.
Statistical Approaches and Predictions
The large amount of molecular features obtained from the 254,235 pixels analyzed makes data
interpretation difficult and calls for the use of sophisticated multivariate statistical techniques
[9,30,31]. First, we implemented the approach we previously developed using the Lasso method
to generate a statistical prediction based on DESI-MSI data [9,28]. To build our Lasso statistical
classifier, a group of 42 samples with regions of clear histologic diagnosis (>90% composition
of a single tissue type) was selected and randomly divided into a training set and a validation
set of samples. Mixed samples with high cellular heterogeneity were evaluated separately as a
test set of samples, and the results were individually analyzed for each sample. The training set
of samples consisted of 25 samples with regions of pancreatic cancer, normal pancreatic glands,
or normal stroma tissue, contributing a total of 45,273 spectra. Using the training set of sam-
ples, the Lasso selected a total of 112m/z values that are important in characterizing all classes
and that yielded the fewest CV errors (Table 1). From those, 59 differentm/z values were
selected by the classifier as important features to characterize pancreatic cancer, and 54m/z
values and 14m/z values were selected as important features to characterize normal pancreatic
Fig 3. Selected 2-D negative ion mode DESI-MSI ion images obtained from pancreatic tissue samples. (A) Ion images ofm/z 281.3 (oleic
acid),m/z 303.3 (arachidonic acid),m/z 788.5 (PS(36:1)),m/z 861.6 (PI(36:2)), andm/z 885.6 (PI(38:4)) for samples PC7817, which is composed
of 90% normal pancreatic glands and 10% normal stromal tissue, sample PC13702, which is composed of 90% pancreatic cancer and 10%
normal stromal tissue, and sample PC0423, which is entirely composed of normal stroma. (B) Optical images of the same tissue sections
subjected to H&E stain and evaluated by histopathology.
doi:10.1371/journal.pmed.1002108.g003
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Table 1. m/z values selected by the Lasso as important for characterizing each class (pancreatic can-
cer, normal pancreatic glands, and normal stroma) and their respective statistical weights.
m/z LassoWeight
Cancer Normal Glands Normal Stroma
150.7 0.152
155.2 −0.012
155.7 0.201
179.2 0.065
180.7 −0.071
186.7 0.060
187.2 0.028
187.7 0.005
189.2 0.034
196.7 0.414
197.7 −0.009 0.028
198.2 0.041
200.2 −0.231
202.7 0.159
204.2 0.252
207.2 0.026
214.7 0.185
215.2 −0.096 0.251
217.2 0.173
233.7 −0.146 0.983
244.7 −0.193
246.7 0.192
247.2 0.306
250.2 0.028
264.7 0.008
265.2 0.008
265.7 0.002
266.2 0.011
267.2 0.002
277.2 −0.069 0.033
282.2 −0.026
306.2 0.118
307.2 0.174
307.7 0.174
308.2 0.110
331.2 0.136
331.7 0.025
332.2 0.202
332.7 0.051 −0.072
333.2 0.133
333.7 −0.017
335.7 0.077
344.2 −0.112
346.2 0.213
347.2 −0.082
(Continued)
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Table 1. (Continued)
m/z LassoWeight
Cancer Normal Glands Normal Stroma
352.7 −0.182 0.063
359.2 −0.180
359.7 −0.058
367.7 0.091
376.7 −0.001
381.7 −0.112
382.7 −0.129
386.2 0.082
391.2 0.065
418.7 0.099
420.7 −0.009
421.7 −0.279
428.2 0.010
441.7 0.287
448.7 −0.230
452.2 0.024
456.7 −0.311
498.7 −0.023
499.2 0.241
499.7 0.074
503.2 0.313
503.7 0.049
506.7 0.138
556.2 0.309
574.7 −0.316
578.2 −0.097 0.173
614.7 0.007 −0.088
615.2 0.028
625.7 −0.073
626.2 0.016
646.7 −0.161
648.2 −0.205
648.7 −0.210
649.2 0.245 −0.131
649.7 0.536 −0.038
650.2 0.224
650.7 0.012 −0.411
669.7 −0.036
710.8 −0.072
724.8 0.069
725.8 0.205
726.8 −0.063
737.8 −0.210
738.3 0.067 −0.064
738.8 0.130 −0.148
746.8 0.018
(Continued)
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glands and normal stroma, respectively. The statistical weight for each informative feature is
calculated by the Lasso depending on the importance that the mass spectral feature has in char-
acterizing a certain class. An ion whose relative abundance is important for characterizing a
certain class is given a positive weight, whereas ions for which low relative abundance or their
absence is important receive a negative weight. In this way, certainm/z values were selected as
important for more than one class, with different statistical weights. For example,m/z 233.7
was selected as important for characterizing both normal glands and stroma tissues, with statis-
tical weights of −0.146 and +0.983, respectively. On the other hand,m/z 738.8 was selected as
important for characterizing pancreatic cancer and normal glands, with statistical weights of
+0.130 and −0.148, respectively.
The Lasso yields a classifier that predicts whether a pixel belongs to a certain class based on
the highest probability assigned of being pancreatic cancer, normal pancreatic glands, or nor-
mal stroma. To test our model using the training set of samples, we performed a 25-fold leave-
one-patient-out CV and evaluated the agreement between the prediction obtained by Lasso
and the diagnosis obtained by histopathologic evaluation of the same tissue section, which
was H&E stained after being imaged by DESI-MSI [26]. An overall agreement of 98.1% was
achieved when the total of 45,273 pixels were analyzed in CV. Table 2 shows the results
obtained for each class. Note that the normal pancreatic gland class showed the highest agree-
ment (99.3%) with pathologic evaluation, followed by the cancer class (96.4%) and the stroma
class (79.9%). There are two key observations that could account for the lower agreement
obtained for the stroma class compared to the other classes. First, only 1,389 pixels in our
classifier corresponded to pure stroma pixels, a number significantly lower than what was
obtained for the other two classes (34,014 pixels of normal pancreatic glands and 9,870 pixels
Table 1. (Continued)
m/z LassoWeight
Cancer Normal Glands Normal Stroma
747.3 0.132
747.8 0.284
752.8 −0.034
760.8 −0.110
775.8 0.057
778.8 0.000 −0.202
780.8 −0.001
788.8 0.030
792.8 0.231
796.8 0.038
797.8 0.143
871.8 −0.139
872.3 −0.121
872.8 −0.125
885.8 0.004
887.8 0.044
892.8 −0.068
896.8 −0.025
904.8 −0.049
906.8 0.223 −0.223
907.8 −0.034
doi:10.1371/journal.pmed.1002108.t001
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of pancreatic cancer). Second, stromal tissue contained the least amount of detectable ions in
the mass spectra, as observed in Fig 2C and, consequentially, the lowest number of statistically
significant features was selected for characterizing this class (14m/z values). Nevertheless,
when normal pancreatic glands and normal stroma were combined into one class of normal
pancreatic tissue, the overall agreement rate increased to 98.7% (Table 3). When we applied
our classification model to a set of 17 independent samples with regions of clear histopatho-
logic diagnosis, an overall agreement rate of 98.6% was achieved for the 31,235 pixels consid-
ered. The results obtained for each tissue class in the validation set are shown in Table 2. Note
that, similarly to the training set of samples, the lowest agreement was observed for the stroma
class (83.8%), compared to the agreement obtained for the normal pancreatic gland (99.8%)
and cancer (95.4%) classes. When normal stroma and normal pancreatic glands were com-
bined into one class, a high overall agreement of 98.9% was achieved for the independent set of
validation samples (Table 3).
To spatially observe the results of our classification system, two-dimensional false-color
images were plotted showing the results for cancer as red pixels, normal pancreatic glands as
green pixels, and normal stroma as blue pixels. These images can be directly compared to the
optical images of the H&E-stained tissues. Fig 4 shows the CV classification results obtained
for samples PC5756 and PC699 from the training set and for samples PC14836 and PC13702
from the validation set. Note that discrepancies in the shapes of the Lasso predicted images and
the DESI-MSI images occurred for some examples due to (1) the segmentation algorithm used
to select regions for statistical analysis, (2) the exclusion of pixels near the boundaries of the tis-
sue section where background ions from glass slide (which do not contribute to the molecular
information) are observed at high intensities, and (3) the suboptimal aspect ratio of the pre-
dicted Lasso images, which required rescaling and adjusting. Optical images of the H&E-
Table 2. Prediction results for the 76,508 pixels analyzed in the training and validation set of samples, in comparison with pathologic analysis.
Pathology Predicted Standard Error Agreement (Percent) Overall Agreement (Percent)
Cancer Glands Stroma
Training set (45,273 pixels) 98.1 (0.06 standard error)
Cancer 9,514 148 208 0.19 96.4
Glands 207 33,787 20 0.05 99.3
Stroma 31 248 1,110 1.08 79.9
Validation set (31,235 pixels) 98.6 (0.07 standard error)
Cancer 6,448 284 25 0.25 95.4
Glands 23 23,814 17 0.03 99.8
Stroma 3 98 523 1.47 83.8
doi:10.1371/journal.pmed.1002108.t002
Table 3. Prediction results for the 76,508 pixels analyzed in the training and validation set of samples, in comparison with pathologic analysis,
with normal stroma and normal pancreatic glands combined into one class.
Pathology Predicted Standard Error Agreement (Percent) Overall Agreement (Percent)
Cancer Normal
Training set (45,273 pixels) 98.6 (0.06 standard error)
Cancer 9,514 356 0.19 96.4
Normal 238 35,165 0.04 99.3
Validation set (31,235 pixels) 98.9 (0.06 standard error)
Cancer 6,448 309 0.25 95.4
Normal 26 24,452 0.02 99.9
doi:10.1371/journal.pmed.1002108.t003
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stained sections with pathologic diagnosis for these samples are shown in Fig 4. As observed,
the discrepancies observed between statistical results and histopathologic evaluation occur for
a low number of pixels within each sample. As our approach is performed and evaluated on a
pixel by pixel basis, this is not surprising: regions with a predominant histologic feature may
contain few cells of a different histologic class.
Statistical Predictions for Mixed Samples
A large number of the samples analyzed in our study contained regions of high cellular hetero-
geneity, with a mixed composition of cancer cells infiltrating normal pancreatic glands and
normal stromal cells. Careful histologic evaluation was performed in order to assign and accu-
rately describe these regions with mixed histologic features. Regions of cellular composition
not accounted for when building our statistical models (such as lymphocytes, acute inflamma-
tion, and necrosis) were excluded from our statistical prediction approach. To assist with the
evaluation of the DESI-MSI/Lasso results, a visual measurement of the percent cell composi-
tion was given by the pathologist for selected regions of the tissue section. For example, sample
PC13336 contained a region of pure normal pancreatic glands, adjacent to a region of 15%
tumor cells and 85% normal pancreatic gland cells. Sample PC12809 presented a mixed com-
position of 20% tumor cells within 80% stromal cells. Sample PC14851 presented 60% tumor
cells mixed within 40% normal pancreatic glands. Sample PC0411 presented a region with
high tumor cell composition (70%) mixed with normal stroma (30%), surrounded by normal
pancreatic glands and stroma. Sample PC14132 presented a region with 60% tumor cells inter-
mingled with normal stroma, while the remaining tissue was composed of both normal pancre-
atic glands and normal stromal tissues. Optical images of the H&E-stained tissue sections
delineated by histopathologic evaluation are shown in Fig 5.
Fig 4. Selected DESI-MSI ion image and Lasso prediction results obtained for training samples
PC5756 and PC699 and validation samples PC14836 and PC13702. (A) Negative ion mode DESI-MSI ion
images ofm/z 303.2,m/z 885.7,m/z 281.3, andm/z 281.3 are shown for samples PC5756, PC699 (pair of
normal pancreas and pancreatic cancer), PC14836, and PC13702, respectively. (B) Lasso prediction results
are shown for each sample, with pixels predicted as pancreatic cancer shown in red, normal pancreatic
glands in green, and normal stroma in blue. (C) Optical images of the H&E-stained tissue sections are shown,
with the regions diagnosed by the pathologist delineated using the same color representation.
doi:10.1371/journal.pmed.1002108.g004
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Due to the complex nature of these samples, the results for each sample were evaluated sep-
arately in order to assess the performance of our approach. The agreement between the
DESI-MSI/Lasso prediction and the diagnosis given by histopathology was evaluated both in
terms of the spatial distribution of pixels and the percent tumor/normal cell composition for
the specific tissue region. For example, an excellent agreement was observed for sample
PC13336, with the region of normal pancreatic glands completely assigned as normal glands,
and the adjacent region of 15% tumor cell concentration and 85% normal pancreatic gland
concentration assigned by the statistical approach as 12% cancer pixels within mostly normal
pancreatic glands (Fig 5). Another sample in which excellent tissue composition and spatial
agreement was observed was PC0411. The region with high tumor cell concentration (70%)
mixed with stroma (30%) as diagnosed by histopathology was correctly classified by our
approach, as well as the surrounding region of normal pancreatic glands and stroma. On the
Fig 5. Statistical predictions in comparison with histopathologic diagnosis for samples of mixed
histology.Results are shown for samples PC13336, PC12809, PC14851, PC0411, and PC14132 using (A)
the Lasso classification system built with the training set of samples and (B) the customized training set
approach. Pixels predicted as pancreatic cancer are shown in red, normal pancreatic glands in green, and
normal pancreatic stroma in blue. (C) Optical images of the H&E-stained tissue sections are shown, with the
regions diagnosed by the pathologist delineated using the same color representation.
doi:10.1371/journal.pmed.1002108.g005
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other hand, sample PC14132 was classified as containing a higher tumor cell composition than
that assessed by histopathology, with regions diagnosed as normal glands assigned as contain-
ing cancer. Overall, results obtained with the developed Lasso approach showed outstanding
agreement with histopathology for both cell concentration and spatial distribution for 70% of
the samples evaluated. For the remaining 30% of samples, the disagreement was caused by
either an overprediction of cancer cell composition (20% of samples) or false-negative predic-
tion (5% samples). Results for the samples described above are shown in Fig 5A.
An alternative approach commonly used to evaluate results from complex samples is the
“majority rule” approach, where an overall agreement is given for an entire sample based on
the majority of the pixels assigned (i.e., if>50% pixels are predicted as cancer, the sample is
predicted as “cancer”). Using the majority rule approach, 95% agreement was achieved for the
mixed samples using our classification system. Nevertheless, because the majority rule
approach disregards important spatial features of the samples, which are crucial for surgical
margin evaluation, we have chosen not to evaluate our results by this method. Instead, in an
effort to optimize our methods for mixed samples, we applied a novel customized training sta-
tistical method using the Lasso recently developed for MS data [29]. This customized training
strategy makes predictions on the test dataset when the features of the test data are available at
the time of model fitting. The data are clustered to find training points close to each test point,
and then the method fits a Lasso model separately in each training cluster. This means that a
customized training set is generated from the data in the training set for each test sample. The
method also generates a separate, unique list of statistically significant features (m/z values) for
each test sample. This procedure, by incorporating an entire dataset of training samples, is use-
ful in situations where complex datasets have underlying structure that could account for diffi-
culties in prediction. When using the customized training approach, our agreement increased
to 81% of all mixed samples analyzed. Increased agreement was mostly observed for samples
that had previously been classified by our approach as having a higher tumor cell composition
than what was assessed by histopathology, with many “false positive” samples now correctly
classified as only normal tissue. For example, sample PC12809, a mixed composition of 20%
tumor cells within 80% stromal cells, was classified as being composed of 81% cancer by our
traditional Lasso approach. Using the customized training set approach, 15% of the pixels were
classified as cancer and the remaining 85% as normal stroma, a much better agreement. Results
for the samples discussed above using this new customized approach are shown in Fig 5B.
Surgical Margin Evaluation
To evaluate the results for the surgical cases in our study, we used the customized training set
approach described above. Thirty-two pancreatic cancer patients were recruited for our study,
and a total of sixty-five samples were collected (Table 4). In most cases, serial sections of at
least one of the margins (neck and/or uncinate) were obtained, as well as a section of the
tumor. The results from DESI-MSI/Lasso analysis were not fed back to the surgeons during the
procedure, but independently evaluated post-operatively. For surgical case PCP4, for example,
a sample of the cancerous tissue as well as sections of the neck and uncinate margins were
obtained during surgical resection and analyzed by DESI-MSI. Histologic evaluation of the sur-
gical margins both intraoperatively and after DESI-MSI diagnosed both margins as negative
for the presence of cancer. The uncinate margin was composed of 90% normal pancreatic
glands and 10% stroma, while the neck margin was composed of normal pancreatic glands
only. The tumor section contained 60% tumor cells, with the remaining being composed of
normal pancreatic glands and stroma. Predictions were performed using the customized train-
ing set approach, and results are shown in Fig 6. As observed, a good agreement between
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histopathologic evaluation and our analysis was achieved. In particular, both margins were
detected as being purely normal, with stroma pixels detected by our classifier for the neck mar-
gin, whereas 55% of pixels were detected as cancerous for the cancer section, as described by
histopathology. Similar results were obtained for the majority of cases with negative margins,
including PCP9 (Fig 6) and PCP31.
For case PCP21, samples of tumor and neck margin were obtained. While the neck margin
was diagnosed as negative by histopathology (95% normal pancreatic glands and 5% normal
stroma), the tumor section contained a region with 80% tumor cell concentration within
stroma cells, and the remaining tissue was diagnosed as tumor infiltrating normal glands and
stroma, with a low tumor cell concentration. Results obtained by our approach are shown in
Fig 6. While high spatial and tumor/normal cell composition agreement was obtained for the
cancerous tissue, a very small number of pixels (2%) within the normal neck margin were
Table 4. Clinicopathologic characteristics of 32 patients who underwent resection of pancreatic can-
cer and were prospectively evaluated.
Characteristic Number (Percent)
Age (years) 69 (46–85)*
Male gender 16 (50%)
Type of operation
Whipple pancreaticoduodenectomy 26 (81%)
Distal pancreatectomy 6 (19%)
T stage
T3 25 (78%)
T2 6 (19%)
T1 1 (3%)
Node positive 20 (62%)
Perineural invasion 22 (69%)
*Median (range).
doi:10.1371/journal.pmed.1002108.t004
Fig 6. Lasso prediction results for cancer andmargin tissues obtained prospectively from surgery in pancreatic cancer patients. Lasso
prediction results are shown for the cancer tissue as well as the surgical margins (uncinate and/or neck) of surgical cases PCP4 (negative
margins), PCP9 (negative margin), PCP21 (negative margin), and PCP14 (positive margin). Pixels predicted as pancreatic cancer are shown in
red, normal pancreatic glands in green, and normal stroma in blue.
doi:10.1371/journal.pmed.1002108.g006
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detected as being cancerous by our method. Note that this error is within the error rates we
obtained when developing the statistical approach. Similar results were observed for other
large margin samples (over 1,000 pixels) evaluated by our classifier, including the negative
neck margins from surgical cases PCP20 and PCP28. Yet an excellent agreement was observed
for the cancerous tissues for both surgical cases PCP20 and PCP28.
PCP14 was the only surgical case for which a positive margin was found intraoperatively for
the uncinate margin. Histologic evaluation of the serial tissue section analyzed in the laboratory
by DESI-MSI also detected the presence of tumor cells within the uncinate margin, about 10%
tumor cell concentration infiltrating within normal glands and normal stroma. This positive
margin was also detected by our DESI-MSI/Lasso approach, with an excellent agreement of
12% pixels detected as cancer among normal glands and stroma. Overall, good agreement
between histopathologic evaluation and the DESI-MSI/Lasso results was obtained in our study
for 24 of the surgical cases evaluated. In four of the remaining surgical cases, a false positive
was observed in surgical margins, with as many as 20% of the pixels classified as cancer by our
approach while diagnosed as normal by histopathology. In the other four cases, a maximum of
2% of pixels were classified as cancerous in surgical margin tissue while diagnosed as normal
by histopathology. It was interesting to note that the median survival after resection for these
eight patients with false-positive margins by DESI-MSI/Lasso but not by histopathologic exam-
ination was only 10 mo, as opposed to 26 mo for patients with negative margins by both
DESI-MSI/Lasso and histopathology (Fig 7). Historically, a median survival of 10 mo is
what one would expect from a margin-positive pancreatic cancer resection and 26 mo from
a margin-negative resection. Although this difference did not reach statistical significance
(p = 0.209), likely due to small sample size, it would be intriguing to hypothesize that our
Fig 7. Kaplan-Meier curves comparing overall survival after surgical resection between patients with
negative surgical margins by both DESI-MSI/Lasso and frozen section analysis and patients with
positive margins by DESI-MSI/Lasso but negative margins by frozen section analysis. The blue line
indicates patients with negative surgical margins by both DESI-MSI/Lasso and frozen section analysis (n =
23, median 26 mo); the green line indicates patients with positive margins by DESI-MSI/Lasso but negative
margins by frozen section analysis (n = 8, median 10 mo). Log-rank test, p = 0.209. One patient in the
prospective arm of the study had positive margins by both techniques and was excluded from this
comparison.
doi:10.1371/journal.pmed.1002108.g007
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method was more “sensitive” than frozen section analysis (the standard method currently) in
detecting margin involvement by tumor in patients who experienced early recurrence and
death. Further study is warranted to prove or disprove the aforementioned hypothesis. False-
negative results were not observed by our approach when evaluating surgical margins. Excel-
lent agreement was observed for all the cancer tissues analyzed from surgical cases.
Discussion
Accurate intraoperative evaluation of resection margins in pancreatic cancer (as with any
oncologic) surgery is critical to overall surgical success and patient survival. In this study, we
used DESI-MSI and the Lasso method to develop an automated system to classify pancreatic
tissue sections based on molecular information. In total, 254,235 individual mass spectra were
considered in our approach, and classified as normal pancreatic glands, normal pancreatic
stromal tissue, or pancreatic cancer. DESI-MSI molecular profiles obtained for the samples
showed high relative abundances of many ions identified as FAs and GPs. The method was
developed and tested using different sets of training and validation samples, and its perfor-
mance was evaluated on a per pixel basis in comparison to histopathologic diagnosis. Using a
set of independent validation samples with unequivocal histologic features, classification
results were in agreement with pathologic diagnosis in 98.6% of the pixels evaluated. The high-
est error value in classification was observed in the normal stroma class, which presented low
abundances of molecular species by DESI-MSI compared to the other tissue classes, and for
which the lowest number of samples/pixels was obtained. A set of complex validation samples
with mixed histologic features was carefully evaluated using a statistical approach that employs
Lasso to generate a customized training set for each test sample considered. The results
obtained were methodically compared with the histopathologic results for both spatial features
and cellular composition in each sample. When judged by both criteria, 81% agreement was
obtained. This is the first study to our knowledge to report the use of ambient ionization MS
imaging for the diagnosis of pancreatic cancer.
We further demonstrated the value of DESI-MSI/Lasso for surgical margin evaluation in
pancreatic cancer surgery using neck and/or uncinate margins and tumor tissues prospectively
collected from 32 surgical procedures performed at Stanford University Hospital. Samples
were imaged and classified using the customized training set approach developed for mixed
samples. Using our method, we were able to correctly diagnose cancer in a case where a positive
neck margin was observed by histopathology. For the remaining cases, all margins were diag-
nosed as negative by histopathologic analysis. In nine of the 32 cases, our method classified pix-
els (1%–20%) in the neck and/or uncinate margin as cancerous while histopathology did not.
This disagreement in diagnosis could be attributed to the inherent error range in our analysis
(~2%), especially for margin samples that are large and contain over 1,000 pixels. However, the
early recurrence and death noted in patients with false-positive margins by DESI-MSI raises
the question as to whether these margins were truly positive, and accurately classified by our
method but not by the histopathologic analysis of frozen sections.
The classification results obtained using Lasso are similar to what has been reported for
other cancers (>90% accuracy in CV) [13]. Improvements in our classification system will be
sought by increasing sample size for stroma tissue, which contributes to most of the confusion
in our classification system. As DESI-MSI is performed in the ambient environment with mini-
mal sample preparation requirements, we believe this technology is attractive for routine use in
clinical practice. Furthermore, as DESI-MSI evaluation is performed in real time, it is typically
faster than frozen section analysis. Note, however, that in this study DESI-MSI was performed
on the entire tissue section in order to unambiguously correlate and compare the molecular
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results with histopathologic diagnosis. In some cases, over 2 h were necessary to image a large
surgical margin tissue. Thus, the timeframe involved in imaging analysis by DESI-MSI could
become a limitation for its routine use in the clinic. However, we expect that in clinical practice,
DESI-MSI analysis would be rapidly performed in selected regions of the tissue that present
diagnostic ambiguity (<1 s/pixel), in a profiling and not imaging mode. In this way, DESI-MSI
would serve as a rapid adjunct technique to the standard method of frozen section analysis,
and thereby enhance intraoperative margin assessment by the pathologist.
Further limitations of incorporating DESI-MSI into clinical practice include the required
staffing resources and cost. Currently, data recording, interpretation, and statistical analysis are
performed after sample analysis, which requires time and expertise. Improvements in compu-
tational methods for data acquisition and processing are necessary to successfully translate the
technology to clinical practice. In addition, current commercially available mass spectrometers
are costly instruments (>$200,000) that require regular maintenance. Yet, as many efforts are
underway to develop smaller and cheaper mass spectrometers, we expect these instruments to
become more accessible to hospitals for clinical use [32,33].
In summary, this study demonstrates that DESI-MSI/Lasso can be successfully used to clas-
sify tissue as normal or pancreatic cancer. Our findings provide evidence that the molecular
information obtained by DESI-MSI/Lasso from tissue samples has the potential to transform
the evaluation of surgical specimens. With further development and automation, we believe
the described methodology could be routinely used for surgical margin assessment of pancre-
atic cancer. Yet, careful evaluation of the long-term benefits to patients of the use of DESI-MSI
for surgical margin evaluation is needed, using a larger cohort of cases, to determine its proper
value in clinical practice.
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